Skip to content
Search

Latest Stories

PSNC launches new political influencing campaign for community pharmacies

The Pharmaceutical Services Negotiating Committee (PSNC) will launch a new influencing campaign to build wider political support for community pharmacies this week.

The campaign aims to ensure that MPs and Peers across Parliament understand the risks to pharmacy services that the current pressures on the sector are causing.


In a Parliamentary event held today (Tuesday 15 November) MPs and Peers heard from PSNC, LPC and other pharmacy bodies about the current situation.

PSNC briefed them on the urgent need for action to address the pressures on the sector.

The committee will be working with LPCs and contractors to organise a series of pharmacy visits for key Parliamentarians including Minsters, Committee and APPG Members.

This is happening alongside work to develop a new vision and strategy for the community pharmacy sector, all of which is part of PSNC’s strategy to lay the ground for future CPCF negotiations.

To help engage with Parliamentarians PSNC have developed a key messaging document which sets out a four-point action plan that it want Government to take immediately.

It will be looking for Parliamentary supporters to ask Government to:

  1. Resolve the funding squeeze: Community pharmacy needs an immediate funding uplift to prevent collapse, as well as emergency business relief to get through this winter.
  2. Tackle regulatory and other burdens: Pharmacies must be protected from medicines market shocks, supported with their workforce crisis, helped to free up capacity and freed from red tape that does not enhance patient care.
  3. Help pharmacies to expand their role in primary care: Pharmacies could do more to support the delivery of primary care for example through offering clinical services for long-term conditions – like hypertension, diabetes and respiratory disease, supporting people to adopt healthier lifestyles and prevent the development of long-term conditions, medicines optimisation, and a much wider variety of NHS vaccinations.
  4. Commission a Pharmacy First service: A fully-funded pharmacy service that allows patients to have walk-in consultations for minor conditions would provide accessible care and ease pressure on general practice.

Zoe Long, PSNC Director of Communications and Public Affairs, said: “Community pharmacies are facing immense, unsustainable operational and financial pressures which are impacting on businesses, staff, and patients. This is not acceptable, and we will be telling politicians across the political spectrum that something must be done about it. Our short-term action plan has been written to help us do that while work continues on the longer-term vision and strategic options for the sector.

The best way for MPs to understand what is going on in pharmacy is to see it for themselves and to talk to contractors directly, and this is why we’ll be looking to organise a series of pharmacy visits over the coming months to support the briefings we are giving across Westminster. We would be very grateful for any help that contractors and LPCs can give with this campaign.”

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less